Immune status against measles and rubella among Chilean subjects of different ages

被引:0
|
作者
Valenzuela, MT [1 ]
Vega, J [1 ]
Leal, I [1 ]
Vicente, M [1 ]
Young, V [1 ]
Vera, L [1 ]
Fasce, R [1 ]
Ramírez, E [1 ]
机构
[1] Minist Salud, Org Panamer Salud, Inst Salud Publ, Programa Ampliado Inmunizac, Santiago, Chile
关键词
measles; rubella; vaccines; antibodies; antibody specificity;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Results of clinical and epidemiological studies confirm that no cases of measles have occurred in Chile since 1993. However, since covering of vaccination programs do not exceed 95%, an immunological surveillance for this disease is warranted. Aim: To know the immune status against measles and rubella in the Chilean population. Material and methods: A serological census of a representative sample of communities with high (90% or more) or low immunization coverings was performed. Four sub samples along the country were selected: 122 children aged 18 months of age (stratum A) 1,276 children attending the first year of basic school (stratum B) 899 teenagers in their last high school year (stratum C) and 399 women attending a family planning clinic (stratum D). IgG antibodies against measles and rubella were measured using ELISA and hemagglutination inhibition techniques, respectively. Results: Antibodies against measles and rubella were found in 96% and 94% of study subjects. No differences in these titres were found between different strata or communities with high or low vaccination covering. There is a high percentage of positive antibodies against measles among children of 18 months of age and high percentage of antibodies against rubella among teenagers and women in family planning. Only 3% of the sample had not received any vaccine at the moment of the study. Conclusions: The high prevalence of antibodies against rubella allows to conclude that it is not necessary to consider this antigen in the next vaccination campaign. Due to the high prevalence of antibodies against measles, only the population older than 20 years old should be affected by the disease if this virus enters the country.
引用
收藏
页码:359 / 365
页数:7
相关论文
共 29 条
  • [1] Assessment of immune status against measles, mumps, and rubella in young Kuwaitis: MMR vaccine efficacy
    Madi, Nada
    Altawalah, Haya
    Alfouzan, Wadha
    Al-Nakib, Widad
    Al-Roumi, Ebtehal
    Jeragh, Ahlam
    JOURNAL OF MEDICAL VIROLOGY, 2020, 92 (08) : 963 - 970
  • [2] Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients
    Kawamura, Koji
    Yamazaki, Rie
    Akahoshi, Yu
    Nakano, Hirofumi
    Ugai, Tomotaka
    Wada, Hidenori
    Yamasaki, Ryoko
    Ishihara, Yuko
    Sakamoto, Kana
    Ashizawa, Masahiro
    Sato, Miki
    Terasako-Saito, Kiriko
    Kimura, Shun-ichi
    Kikuchi, Misato
    Nakasone, Hideki
    Kanda, Junya
    Kako, Shinichi
    Tanihara, Aki
    Nishida, Junji
    Kanda, Yoshinobu
    HEMATOLOGY, 2015, 20 (02) : 77 - 82
  • [3] Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
    Saffar, Hana
    Khalifeloo, Maryam
    Saffar, Mohammad-Jafar
    Abdollahi, Alireza
    Parsaei, Mohammad-Reza
    Ghorbani, Gholam-Reza
    Salarvand, Samaneh
    Aarabi, Mohsen
    BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [4] Measles and rubella serosusceptibity among population vaccinated with different schedules: the potential impact on measles-rubella elimination in Iran
    Hana Saffar
    Maryam Khalifeloo
    Mohammad-Jafar Saffar
    Alireza Abdollahi
    Mohammad-Reza Parsaei
    Gholam-Reza Ghorbani
    Samaneh Salarvand
    Mohsen Aarabi
    BMC Infectious Diseases, 21
  • [5] Long-term Neutralizing Antibody Levels Against Measles and Rubella Viruses Among Adults With 3 Doses of Measles-Mumps-Rubella Vaccine
    Alonge, Oluwakemi D.
    Marin, Mona
    Hickman, Carole J.
    Sowers, Sun B.
    Chen, Min-hsin
    Hao, Lijuan
    Mercader, Sara
    El-Badry, Elina
    McClure, David L.
    Icenogle, Joseph P.
    Sugerman, David E.
    Crooke, Stephen N.
    Nguyen, Huong Q.
    OPEN FORUM INFECTIOUS DISEASES, 2024, 11 (01):
  • [6] Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella
    Tischer, A
    Gerike, E
    VACCINE, 2000, 18 (14) : 1382 - 1392
  • [7] Vaccination Status and Antibody Titers against Rubella and Measles among Japanese Female College Students Majoring in Childcare between 2015 and 2018
    Shoho, Yoshifumi
    Kimura, Takao
    Yanagawa, Yoshimaro
    Saito, Ai
    Inoue, Toshiya
    Suto, Chiaki
    Tsunekawa, Katsuhiko
    Araki, Osamu
    Nara, Makoto
    Tokue, Yutaka
    Murakami, Masami
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2018, 246 (02) : 73 - 79
  • [8] STATUS OF IMMUNITY TO TETANUS, MEASLES, MUMPS, RUBELLA, AND POLIO AMONG UNITED-STATES TRAVELERS
    HILTON, E
    SINGER, C
    KOZARSKY, P
    SMITH, MA
    LARDIS, MP
    BORENSTEIN, MT
    ANNALS OF INTERNAL MEDICINE, 1991, 115 (01) : 32 - 33
  • [9] Rubella immune status of neonates - a window towards seroprevalence among childbearing women
    Pejcic, Iris
    Janevski, Milica Rankovic
    Knezevic, Aleksandra
    Jevtovic, Djordje
    Stanojevic, Maja
    BMC PUBLIC HEALTH, 2016, 16
  • [10] Rubella immune status among immigrant and nonimmigrant women in Spain
    Ramos, J. M.
    Milla, A.
    Rodriguez, J. C.
    Gutierrez, F.
    JOURNAL OF MEDICAL VIROLOGY, 2012, 84 (03) : 548 - 550